STELLARIS PHARMACEUTICALS ApS: Financial statements 2023
CVR: 34708215
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
STELLARIS PHARMACEUTICALS ApS (CVR 34708215) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -255,845 and a net result of DKK -803,430 compared with DKK -785,988 the year before. Equity in the 2023 report amounted to DKK -2,483,993. The company had 1 employee in the financial year.
- Gross Profit
- DKK -255,845
- Profit/Loss
- DKK -803,430
- Equity
- DKK -2,483,993
- Total Assets
- DKK 388,488
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -256 t. | -803 t. | -2.5 mio. | 1 |
| 2022 | - | -162 t. | -786 t. | -1.7 mio. | 1 |
| 2021 | - | -102 t. | -539 t. | -895 t. | 1 |
| 2020 | - | -101 t. | -79 t. | -356 t. | - |
| 2019 | - | -71 t. | -58 t. | -277 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
STELLARIS PHARMACEUTICALS ApS has published its annual report for 2022. Gross profit came to DKK -162,405, and the net result was DKK -785,988.
About STELLARIS PHARMACEUTICALS ApS
STELLARIS PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2012. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Birgit Ter-Borch Gram Lilienfeldt Schjoldager. The company is owned by Ranoda Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -475,262 and a net result of DKK -594,882 compared with DKK -486,941 the year before. Equity in the 2025 report amounted to DKK -3,565,816.